0001209191-13-030665.txt : 20130604 0001209191-13-030665.hdr.sgml : 20130604 20130604202852 ACCESSION NUMBER: 0001209191-13-030665 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130604 FILED AS OF DATE: 20130604 DATE AS OF CHANGE: 20130604 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Insys Therapeutics, Inc. CENTRAL INDEX KEY: 0001516479 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 510327886 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10220 SOUTH 51ST STREET STREET 2: SUITE 2 CITY: PHOENIX STATE: AZ ZIP: 85044 BUSINESS PHONE: 602-910-2617 MAIL ADDRESS: STREET 1: 10220 SOUTH 51ST STREET STREET 2: SUITE 2 CITY: PHOENIX STATE: AZ ZIP: 85044 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Babich Michael L CENTRAL INDEX KEY: 0001368078 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35902 FILM NUMBER: 13892967 MAIL ADDRESS: STREET 1: TWO BALA PLAZA STREET 2: SUITE 300 CITY: BALA CYNWYD STATE: PA ZIP: 19004 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2013-06-04 0 0001516479 Insys Therapeutics, Inc. INSY 0001368078 Babich Michael L 444 SOUTH ELLIS STREET CHANDLER AZ 85224 1 1 0 0 President and CEO Common Stock 2013-06-04 4 P 0 1250 10.9287 A 77557 D The weighted average sales price for the transaction reported was $10.92872, and the range of prices were between $10.924 and $10.9299. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. /s/ Michael Babich 2013-06-04